A Randomized Trial of a New Triple Drug Treatment for Lymphatic Filariasis

BACKGROUND: The recommended drug regimen for elimination of lymphatic filariasis outside sub-Saharan Africa is single dose of diethylcarbamazine (DEC) plus albendazole (ALB). Multiple annual treatments are required for elimination since this regimen does not sustainably reduce blood microfilaria (Mf...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Christopher L., Suamani, James, Sanuku, Nelly, Cheng, Yao-Chieh, Satofan, Samson, Mancuso, Brooke, Robinson, Leanne J., Siba, Peter M., Weil, Gary J., Kazura, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194477/
https://www.ncbi.nlm.nih.gov/pubmed/30403937
http://dx.doi.org/10.1056/NEJMoa1706854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194477/
https://www.ncbi.nlm.nih.gov/pubmed/30403937
http://dx.doi.org/10.1056/NEJMoa1706854

Ejemplares similares